Veradermics Inc (MANE) shares fell 4.8% on Monday after Montanova Capital, LLC disclosed the sale of 750,000 common shares in a regulatory filing.
The transactions, documented in a Form 4 filed with the U.S. Securities and Exchange Commission, were executed on August 19 and August 20 at a price of $107.25 per share. The filing listed two separate sales totaling 750,000 shares, including 690,601 shares and 59,399 shares.
Montanova Capital also acquired pre-funded warrants for 149,000 shares and 151,000 shares on August 20, according to the filing. Following these transactions, entities affiliated with Montanova Capital hold 3,106,937 shares and 612,033 shares indirectly through Averill Master Fund and Averill Madison Master Fund.
Aaron Cowen, who may be deemed to control Montanova Capital, disclaimed beneficial ownership except for any indirect pecuniary interest. David Friedman, a managing director and senior analyst at Montanova Capital, serves on Veradermics' board of directors, which may raise governance considerations.
The stock's decline reflects investor reaction to the insider sale disclosure, though the filing does not indicate the purpose or intended use of proceeds from the transactions.
